Pharmacogenetics

Pharmacogenetics Submit Abstract Register Now

Pharmacogenetics is the study of inherited genetic differences in drug metabolic pathways which can affect individual responses towords the drugs, both in their terms of therapeutic effect as well as adverse effects. In oncology, pharmacogenetics historically is the study of germ line mutations (e.g., single-nucleotide polymorphisms affecting genes coding for liver enzymes responsible for drug deposition and pharmacokinetics), whereas pharmacogenomics refers to somatic mutations in tumoral DNA leading to alteration in drug response. 

  • a. Translational Pharmacogenomics b. Cancer Pharmacogenomics c. Pharmacogenitics & Individualized therapy

Related Conference of Pharmacogenetics

November 17-18, 2025

18th International Conference on Human Genomics and Genomic Medicine

Paris, France
March 09-10, 2026

21th World Congress on Tissue Engineering Regenerative Medicine and Stem Cell Research

Singapore City, Singapore
April 16-17, 2026

19th World Congress on Stem Cell Research

Tokyo, Japan
April 23-24, 2026

9th Annual Conference on Stem Cell and Regenerative Medicine

Dubai, UAE
May 04-05, 2026

14th World Congress on Human Genetics and Genetic Diseases

Paris, France
May 25-26, 2026

20th International Conference on Regenerative Repair and Medicine

Madrid, Spain
June 08-09, 2026

9th Global Conference on Cell and Gene Therapy

Rome, Italy
June 15-16, 2026

22nd Global Summit on Stem Cell & Regenerative Medicine

Amsterdam, Netherlands
June 15-16, 2026

13th World Congress on Epigenetics and Chromosome

Paris, France
June 18-19, 2026

16th International Conference on Human Genetics and Genetic Diseases

Singapore City, Singapore
June 18-19, 2026

19th International Conference on Genomics & Pharmacogenomics

Singapore City, Singapore
September 25-26, 2025

6th Annual summit on Cell Signaling and Cancer Therapy

Montreal, Canada

Pharmacogenetics Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in